CAS: 1354744-91-4; (4R,4As,7S,7Ar,12Bs)-7-[2-[2-[2-[2-[2-[2-(2-Methoxyethoxy)Ethoxy]Ethoxy]Ethoxy]Ethoxy]Ethoxy]Ethoxy]-3-Prop-2-Enyl-1,2,4,5,6,7,7A,13-Octahydro-4,12-Methanobenzofuro[3,2-E]Isoquinoline-4A,9-Diol,Oxalic Acid

主要参考文献

1: Al-Huniti N. Reply to: Letter to the Editor "Effect of Quinidine, a Strong P-Glycoprotein Inhibitor, on the Pharmacokinetics and Central Nervous System Distribution of Naloxegol". J Clin Pharmacol. 2016 Apr;56(4):508. doi: 10.1002/jcph.674. doi: 10.1002/jcph.651. doi: 10.1001/jama.2015.17459. doi: 10.1136/dtb.2015.12.0369. doi: 10.1177/2050640615604543.
7: Naloxegol (Movantik) for opioid-induced constipation. Med Lett Drugs Ther. 2015 Sep 28;57(1478):135-7. Review. doi: 10.1358/dot.2015.51.8.2364896. Review. doi: 10.5414/CP202276.
10: Al-Huniti N, Chapel S, Xu H, Bui KH, Sostek M. Population pharmacokinetics of naloxegol in a population of 1247 healthy subjects and patients. Br J Clin Pharmacol. 2016 Jan;81(1):89-100. doi: 10.1111/bcp.12756. Epub 2015 Oct 27.

合成参考文献

参考文献:10.1007/978-3-030-81526-4_7
摘要:Poon A, Ing J, Hsu E. Opioid-Related Side Effects and Management. Cancer Treat Res. 2021;182():97–105. doi: 10.1007/978-3-030-81526-4_7.
参考文献:10.1007/bf00667748
摘要:Stähler E, Neumann HO, Niethammer KM. Metabolism and ultrastructure in ovaries of alloxan-diabetic juvenile rats. Archives of Gynecology and Obstetrics. 1976 Sep;220(3):199–208. doi: 10.1007/bf00667748.